Jürgen van de Lagemaat

Jürgen has more than 15 years of experience in the biopharmaceutical industry as a bioprocessing professional with extensive knowledge in mammalian cell culture and fungal fermentation. He is a leader with a successful track record as a line manager, project manager, and subject matter expert in the mid-to-late-stage development and commercialization of biopharmaceuticals.

Prior to joining Xenikos in 2019, Jürgen was the Upstream Process Technology Lead at MSD Netherlands, where he managed a team of senior scientists in various programs focused on developing cell culture procedures for biotherapeutic proteins such as monoclonal antibodies (mAbs) and gonadotropins. Jürgen previously worked as a Product Steward at MSD and was responsible for providing global technical and scientific support of the upstream manufacturing of mAbs for Keytruda® (pembrolizumab), MSD’s immuno-oncology blockbuster. Prior to MSD, he worked at Organon in upstream process development.

At Xenikos, Jürgen is responsible for the development and commercialization of the manufacturing process for T-Guard® and other products.